Key result
In patients on chronic clozapine therapy, NT-proBNP predicted left ventricular dysfunction with an area under the curve of 0.87, and subclinical dysfunction was found in 3 of 38 patients.
Why the study?
Are NT-proBNP and echocardiography useful in the diagnosis of subclinical left ventricular dysfunction in patients on chronic clozapine therapy?
Cross-Sectional (n=38)
Are NT-proBNP and echocardiography useful in the diagnosis of subclinical left ventricular dysfunction in patients on chronic clozapine therapy?
NT-proBNP and echocardiography are useful diagnostic tools for identifying subclinical clozapine-related cardiotoxicity, which occurs in a notable proportion of treated patients.
Answers are grounded in this paper and cite their sources.
NT-proBNP may aid detection of subclinical LV dysfunction on clozapine; leaves open whether screening improves outcomes in prospective studies.
BACKGROUND: Available information regarding clozapine-related cardiomyopathy is limited to reports of severe left ventricular dysfunction not rarely with fatal clinical evolution. A subclinical cardiotoxic effect might be diagnosed using echocardiography and N-terminal pro-B-type natriuretic peptide assay. METHODS: Thirty-eight patients with psychotic disorder in chronic therapy with clozapine (24 male and 14 female subjects; mean age, 38.4 years) were enrolled. Left ventricular ejection fraction (LVEF) was measured by area-length method (average of 5 measurements). RESULTS: Twelve patients showed a mild depression of left ventricular function (LVEF between 50% and 55%), 2 LVEF less than 50% and 1 less than 30%. The area under the receiver operating characteristic curve for N-terminal pro-B-type natriuretic peptide as a predictor of left ventricular dysfunction was 0.87. CONCLUSIONS: A subclinical left ventricular dysfunction was found in 3 of 38 patients, whereas a mild impairment of the left ventricular systolic function occurred in 1 of 3 of young, previously healthy, clozapine-treated patients A prospective study in clozapine-naive patients may be useful to better understand cardiotoxic effects of clozapine.
No takes yet. Share an insight, caveat, or question.
Rostagno et al. (2011) conducted a cross-sectional in Psychotic disorder (n=38). NT-proBNP and Echocardiography was evaluated on Left ventricular dysfunction (AUC 0.87). In patients on chronic clozapine therapy, NT-proBNP predicted left ventricular dysfunction with an area under the curve of 0.87, and subclinical dysfunction was found in 3 of 38 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: